214 related articles for article (PubMed ID: 27406819)
1. Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors.
Mingozzi F; Spreafico R; Gorletta T; Cigni C; Di Gioia M; Caccia M; Sironi L; Collini M; Soncini M; Rusconi M; von Andrian UH; Chirico G; Zanoni I; Granucci F
EMBO Mol Med; 2016 Sep; 8(9):1039-51. PubMed ID: 27406819
[TBL] [Abstract][Full Text] [Related]
2. IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes.
Schartz NE; Chaput N; Taieb J; Bonnaventure P; Trébeden-Nègre H; Terme M; Ménard C; Lebbé C; Schimpl A; Ardouin P; Zitvogel L
Eur J Immunol; 2005 Oct; 35(10):2840-50. PubMed ID: 16163668
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.
Morandi B; Mortara L; Chiossone L; Accolla RS; Mingari MC; Moretta L; Moretta A; Ferlazzo G
PLoS One; 2012; 7(6):e39170. PubMed ID: 22723958
[TBL] [Abstract][Full Text] [Related]
4. Dynamic behavior of NK cells during activation in lymph nodes.
Beuneu H; Deguine J; Breart B; Mandelboim O; Di Santo JP; Bousso P
Blood; 2009 Oct; 114(15):3227-34. PubMed ID: 19667398
[TBL] [Abstract][Full Text] [Related]
5. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.
Tsujimoto H; Uchida T; Efron PA; Scumpia PO; Verma A; Matsumoto T; Tschoeke SK; Ungaro RF; Ono S; Seki S; Clare-Salzler MJ; Baker HV; Mochizuki H; Ramphal R; Moldawer LL
J Leukoc Biol; 2005 Oct; 78(4):888-97. PubMed ID: 16033815
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-NK cell cross-talk: regulation and physiopathology.
Zitvogel L; Terme M; Borg C; Trinchieri G
Curr Top Microbiol Immunol; 2006; 298():157-74. PubMed ID: 16323415
[TBL] [Abstract][Full Text] [Related]
7. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.
Terme M; Tomasello E; Maruyama K; Crépineau F; Chaput N; Flament C; Marolleau JP; Angevin E; Wagner EF; Salomon B; Lemonnier FA; Wakasugi H; Colonna M; Vivier E; Zitvogel L
J Immunol; 2004 May; 172(10):5957-66. PubMed ID: 15128777
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis Lipopolysaccharide Induced Proliferation and Activation of Natural Killer Cells in Vivo.
Wang Y; Zhang W; Xu L; Jin JO
Molecules; 2016 Aug; 21(8):. PubMed ID: 27548133
[TBL] [Abstract][Full Text] [Related]
9. Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists.
Uchida T; Scumpia PO; Murasko DM; Seki S; Woulfe S; Clare-Salzler MJ; Moldawer LL
J Immunol; 2007 Mar; 178(6):3886-92. PubMed ID: 17339488
[TBL] [Abstract][Full Text] [Related]
10. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells.
Watt SV; Andrews DM; Takeda K; Smyth MJ; Hayakawa Y
J Immunol; 2008 Oct; 181(8):5323-30. PubMed ID: 18832688
[TBL] [Abstract][Full Text] [Related]
12. IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions.
Zanoni I; Spreafico R; Bodio C; Di Gioia M; Cigni C; Broggi A; Gorletta T; Caccia M; Chirico G; Sironi L; Collini M; Colombo MP; Garbi N; Granucci F
Cell Rep; 2013 Sep; 4(6):1235-49. PubMed ID: 24055061
[TBL] [Abstract][Full Text] [Related]
13. [Role of dendritic cells in the modulation of innate effectors of immunity].
Terme M; Masurier C; Fernandez N; Lacassagne MN; Marolleau JP; Zitvogel L
Pathol Biol (Paris); 2001 Jul; 49(6):475-7. PubMed ID: 11484608
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) cell functions can be strongly boosted by activated dendritic cells (DC).
Granucci F; Zanoni I; Ricciardi-Castagnoli P
Eur J Immunol; 2006 Oct; 36(10):2819-20. PubMed ID: 17013979
[No Abstract] [Full Text] [Related]
16. Semaphorin-3E Produced by Immature Dendritic Cells Regulates Activated Natural Killer Cells Migration.
Alamri A; Rahman R; Zhang M; Alamri A; Gounni AS; Kung SKP
Front Immunol; 2018; 9():1005. PubMed ID: 29867980
[TBL] [Abstract][Full Text] [Related]
17. Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy.
Jiang D; Gao T; Liang S; Mu W; Fu S; Liu Y; Yang R; Zhang Z; Liu Y; Zhang N
ACS Appl Mater Interfaces; 2021 May; 13(19):22213-22224. PubMed ID: 33955746
[TBL] [Abstract][Full Text] [Related]
18. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
19. Novel Targeting to XCR1
Kitazawa Y; Ueta H; Sawanobori Y; Katakai T; Yoneyama H; Ueha S; Matsushima K; Tokuda N; Matsuno K
Front Immunol; 2019; 10():1195. PubMed ID: 31191552
[TBL] [Abstract][Full Text] [Related]
20. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
